Adaptive Biotechnologies (NASDAQ: ADPT) insider plans multimillion stock sale
Harlan Robins, an insider at Adaptive Biotechnologies (ADPT), has filed a Form 144 indicating an intent to sell 300,992 shares of common stock, valued at over $7.45 million, through Goldman Sachs & Co. LLC on or after August 17, 2026. The shares were acquired …